ClinicalTrials.gov
public full text
Public Domain
Anti-Inflammatory Lipid Mediators in Asthma
The purpose of this study is to demonstrate the efficacy and safety of 10-nitro-9(E)-octadec-9-enoic acid (CXA-10) in obese adult asthmatics. The study's hypothesis is that 150 mg/day of CXA-10 for 12 weeks will alleviate obesity-related airway hyper-reactivity in obese adult asthmatics.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Risk Factors Associated to Difficult-to-control Asthma#1103470
- Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction#916917
- Milk Fat Intake and Metabolic Health Markers#896997
- Refined obesity, smoking exposure, and lipid metrics in mortality risk assessment: a nationwide cohort analysis#309452
- Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids#802894
Record · ID 1213995
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive